Skip to content
Home
Stock Info
NYSE:IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Press Releases
SEC Filing
Company
Our Team
Governance
ESG
Home
Stock Info
NYSE:IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Press Releases
SEC Filing
Company
Our Team
Governance
ESG
Search
Press Releases
All Years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a “Buy” Recommendation and $3.50 Price Target
July 18, 2024
Read More →
Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile
July 9, 2024
Read More →
IGC Pharma’s TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer’s Disease
June 25, 2024
Read More →
IGC Reports Financial Results for Fiscal Year Ended March 31, 2024
June 24, 2024
Read More →
IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
June 18, 2024
Read More →
IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta-9-tetrahydrocannabinol
June 10, 2024
Read More →
IGC Pharma Announces Patient Enrollment at Neurostudies, Inc. in Phase 2 Trial Investigating IGC-AD1
May 28, 2024
Read More →
IGC Pharma to Attend BIO International Convention 2024
May 21, 2024
Read More →
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
April 16, 2024
Read More →
IGC Pharma Adds Advisor in Artificial Intelligence
April 9, 2024
Read More →
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
March 26, 2024
Read More →
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
March 20, 2024
Read More →
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
March 20, 2024
Read More →
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
March 12, 2024
Read More →
Promising Results: TGR-63 Enhances Memory in Alzheimer’s Mouse Model
February 28, 2024
Read More →
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a Buy Recommendation and $3.00 Price Target
February 23, 2024
Read More →
